Although EBV + DLBCL is characterized by increased PD-L1 expression, our retrospective approach meant that PD-L1 expression levels were not assessed in some patients, and further measurements were absent when the disease became refractory. This evidence concerns the gene CD274 and diffuse large B-cell lymphoma.